Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Osteoarthritis Cartilage ; 22(7): 1007-17, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24795271

RESUMO

OBJECTIVE: When endoplasmic reticulum (ER) stress, i.e., the excessive accumulation of unfolded proteins in ER, endangers homeostasis, apoptosis is induced by C/EBP homologous protein (Chop). In osteoarthritis (OA) cartilage, Chop expression and apoptosis increase as degeneration progresses. We investigated the role of Chop in murine chondrocyte apoptosis and in the progression of cartilage degeneration. METHOD: We induced experimental OA in Chop-knockout (Chop(-/-)) mice by medial collateral ligament transection and meniscectomy and compared cartilage degeneration, apoptosis, and ER stress in Chop(-/-)- and wild-type (Chop(+/+)) mice. In our in vitro experiments we treated murine Chop(-/-) chondrocytes with the ER stress inducer tunicamycin (TM) and evaluated apoptosis, ER stress, and chondrocyte function. RESULTS: In vivo, the degree of ER stress was similar in Chop(-/-)- and Chop(+/+) mice. However, in Chop(-/-) mice apoptosis and cartilage degeneration were lower by 26.4% and 42.4% at 4 weeks, by 26.8% and 44.9% at 8 weeks, and by 26.9% and 32.3% at 12 weeks after surgery than Chop(+/+) mice, respectively. In vitro, the degree of ER stress induction by TM was similar in Chop(-/-)- and Chop(+/+) chondrocytes. On the other hand, apoptosis was 55.3% lower and the suppression of collagen type II and aggrecan mRNA was 21.0% and 23.3% less, and the increase of matrix metalloproteinase-13 mRNA was 20.0% less in Chop(-/-)- than Chop(+/+) chondrocytes. CONCLUSION: Our results indicate that Chop plays a direct role in chondrocyte apoptosis and that Chop-mediated apoptosis contributes to the progression of cartilage degeneration in mice.


Assuntos
Apoptose/fisiologia , Doenças das Cartilagens/patologia , Doenças das Cartilagens/fisiopatologia , Cartilagem Articular/patologia , Condrócitos/patologia , Estresse do Retículo Endoplasmático/fisiologia , Fator de Transcrição CHOP/fisiologia , Agrecanas/metabolismo , Animais , Cartilagem Articular/fisiopatologia , Células Cultivadas , Condrócitos/efeitos dos fármacos , Condrócitos/metabolismo , Colágeno Tipo II/metabolismo , Modelos Animais de Doenças , Progressão da Doença , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Homeostase/fisiologia , Técnicas In Vitro , Metaloproteinase 13 da Matriz/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Fator de Transcrição CHOP/deficiência , Fator de Transcrição CHOP/genética , Tunicamicina/farmacologia
2.
Apoptosis ; 16(4): 438-48, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21274633

RESUMO

C/EBP homologous protein (CHOP) has been proposed as a key transcription factor for endoplasmic reticulum (ER) stress-mediated ß-cell death induced by inflammatory cytokines in vitro. However, the contribution of CHOP induction to the pathogenesis of type 1 diabetes is not yet clear. To evaluate the relevance of CHOP in the pathogenesis of type 1 diabetes in vivo, we generated CHOP-deficient non-obese diabetic (NOD.Chop (-/-)) mice. CHOP deficiency did not affect the development of insulitis and diabetes and apoptosis in ß-cells. Interestingly, NOD.Chop (-/-) mice exhibited a delayed appearance of insulin autoantibodies compared to wild-type (wt) mice. Adoptive transfer with the diabetogenic, whole or CD8(+)-depleted splenocytes induced ß-cell apoptosis and the rapid onset of diabetes in the irradiated NOD.Chop (-/-) recipients with similar kinetics as in wt mice. Expression of ER stress-associated genes was not significantly up-regulated in the islets from NOD.Chop (-/-) compared to those from wt mice or NOD-scid mice. These findings suggest that CHOP expression is independent of the development of insulitis and diabetes but might affect the early production of insulin autoantibodies in the NOD mouse.


Assuntos
Autoanticorpos/biossíntese , Deleção de Genes , Insulina/imunologia , Estado Pré-Diabético/imunologia , Estado Pré-Diabético/patologia , Fator de Transcrição CHOP/genética , Transferência Adotiva , Animais , Apoptose , Autoanticorpos/imunologia , Linfócitos T CD8-Positivos/imunologia , Retículo Endoplasmático/genética , Retículo Endoplasmático/patologia , Regulação da Expressão Gênica , Marcação In Situ das Extremidades Cortadas , Células Secretoras de Insulina/metabolismo , Células Secretoras de Insulina/patologia , Depleção Linfocítica , Camundongos , Camundongos Endogâmicos NOD , Peroxidase/metabolismo , Baço/imunologia , Estresse Fisiológico/genética , Fator de Transcrição CHOP/metabolismo
3.
Cell Death Differ ; 11(4): 381-9, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-14685163

RESUMO

Endoplasmic reticulum (ER) is the site of synthesis and folding of secretory proteins. Perturbations of ER homeostasis affect protein folding and cause ER stress. ER can sense the stress and respond to it through translational attenuation, upregulation of the genes for ER chaperones and related proteins, and degradation of unfolded proteins by a quality-control system. However, when the ER function is severely impaired, the organelle elicits apoptotic signals. ER stress has been implicated in a variety of common diseases such as diabetes, ischemia and neurodegenerative disorders. One of the components of the ER stress-mediated apoptosis pathway is C/EBP homologous protein (CHOP), also known as growth arrest- and DNA damage-inducible gene 153 (GADD153). Here, we summarize the current understanding of the roles of CHOP/GADD153 in ER stress-mediated apoptosis and in diseases including diabetes, brain ischemia and neurodegenerative disease.


Assuntos
Proteínas Estimuladoras de Ligação a CCAAT/metabolismo , Retículo Endoplasmático/metabolismo , Estresse Fisiológico/metabolismo , Fatores de Transcrição/metabolismo , Animais , Apoptose/fisiologia , Proteínas Estimuladoras de Ligação a CCAAT/química , Diferenciação Celular/fisiologia , Divisão Celular/fisiologia , Doença/etiologia , Humanos , Camundongos , Fator de Transcrição CHOP , Fatores de Transcrição/química
4.
Cell Death Differ ; 11(4): 390-402, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-14752510

RESUMO

We reported that the endoplasmic reticulum (ER) stress pathway involving CHOP, a member of the C/EBP transcription factor family, plays a key role in nitric oxide (NO)-mediated apoptosis of macrophages and pancreatic beta cells. We also showed that the cytosolic chaperone pair of hsp70 and dj1 (hsp40/hdj-1) or dj2 (HSDJ/hdj-2) prevents NO-mediated apoptosis upstream of cytochrome c release from mitochondria. To analyze roles of the chaperone pair in preventing apoptosis, RAW 264.7 macrophages stably expressing hsp70 and dj1 or dj2 were established. The chaperone pair prevented LPS/IFN-gamma-induced and NO-mediated apoptosis downstream of CHOP induction. hsp70 mutant protein lacking the ATPase domain or the C-terminal EEVD sequence were not effective in preventing CHOP-induced apoptosis. A mutant dj2 lacking the C-terminal prenylation CaaX motif, was also not effective. When wild-type RAW 264.7 cells were treated with LPS/IFN-gamma, NO-mediated apoptosis was induced, and proapoptotic Bcl-2 family protein Bax was translocated from cytosol to mitochondria. This translocation was prevented in cells stably expressing hsp70/dj2, and in CHOP knockout cells. Overexpression of CHOP in wild-type cells also induced translocation of Bax and this translocation was prevented in cells expressing hsp70/dj2. CHOP-induced apoptosis was prevented by Bax knock-down. Coimmunoprecipitation experiments showed that Bax interacts with both hsp70 and dj1/dj2. ATPase domain of hsp70 was necessary for the binding with Bax. These findings indicate that CHOP-induced apoptosis is mediated by translocation of Bax from the cytosol to the mitochondria, and hsp70/dj1 or dj2 chaperone pair prevents apoptosis by interacting with Bax and preventing translocation to the mitochondria.


Assuntos
Proteínas Estimuladoras de Ligação a CCAAT/antagonistas & inibidores , Proteínas de Choque Térmico HSP70/fisiologia , Proteínas de Choque Térmico/fisiologia , Chaperonas Moleculares/farmacologia , Óxido Nítrico/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-bcl-2 , Proteínas Proto-Oncogênicas/metabolismo , Fatores de Transcrição/antagonistas & inibidores , Adenosina Trifosfatases/metabolismo , Animais , Apoptose/fisiologia , Proteínas Estimuladoras de Ligação a CCAAT/metabolismo , Células COS , Linhagem Celular , Chlorocebus aethiops , Citosol/metabolismo , Proteínas de Choque Térmico HSP40 , Proteínas de Choque Térmico HSP70/genética , Proteínas de Choque Térmico/genética , Macrófagos/citologia , Macrófagos/metabolismo , Camundongos , Camundongos Knockout , Mitocôndrias/metabolismo , Chaperonas Moleculares/metabolismo , Transporte Proteico/fisiologia , Proteínas Proto-Oncogênicas/antagonistas & inibidores , Fator de Transcrição CHOP , Fatores de Transcrição/metabolismo , Transfecção , Proteína X Associada a bcl-2
5.
Cell Death Differ ; 11(4): 403-15, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-14752508

RESUMO

Brain ischemia induces apoptosis in neuronal cells, but the mechanism is not well understood. When wild-type mice were subjected to bilateral common carotid arteries occlusion (BCCAO) for 15 min, apoptosis-associated morphological changes and appearance of TUNEL-positive cells were observed in the striatum and in the hippocampus at 48 h after occlusion. RT-PCR analysis revealed that mRNAs for ER stress-associated proapoptotic factor CHOP and an ER chaperone BiP are markedly induced at 12 h after BCCAO. Immunohistochemical analysis showed that CHOP protein is induced in nuclei of damaged neurons at 24 h after occlusion. In contrast, ischemia-associated apoptotic loss of neurons was decreased in CHOP(-/-) mice. Primary hippocampal neurons from CHOP(-/-) mice were more resistant to hypoxia-reoxygenation-induced apoptosis than those from wild-type animals. These results indicate that ischemia-induced neuronal cell death is mediated by the ER stress pathway involving CHOP induction.


Assuntos
Apoptose/fisiologia , Isquemia Encefálica/metabolismo , Proteínas Estimuladoras de Ligação a CCAAT/metabolismo , Retículo Endoplasmático/metabolismo , Neurônios/metabolismo , Estresse Fisiológico/metabolismo , Fatores de Transcrição/metabolismo , Animais , Proteínas Estimuladoras de Ligação a CCAAT/genética , Artéria Carótida Primitiva/fisiologia , Corpo Estriado/metabolismo , Hipocampo/metabolismo , Hipóxia Encefálica/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Fator de Transcrição CHOP , Fatores de Transcrição/genética
6.
FEBS Lett ; 506(2): 135-9, 2001 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-11591387

RESUMO

Excessive nitric oxide (NO) has been implicated in neurotoxicity after stresses such as ischemia. NO toxicity is generally thought to be mediated by the DNA damage-p53 pathway or mitochondrial dysfunction. We investigated the mechanism of NO toxicity by using murine microglial MG5 cells established from p53-deficient mice. When MG5 cells were exposed to bacterial lipopolysaccharide plus interferon-gamma, mRNA and protein for inducible NO synthase (iNOS) were markedly induced, and apoptosis occurred. Under these conditions, we found that mRNA and protein for CHOP/GADD153, a C/EBP family transcription factor which is involved in endoplasmic reticulum (ER) stress-induced apoptosis, are induced. iNOS mRNA was induced 2 h after treatment, whereas CHOP mRNA began to increase at 6 h with a time lag. CHOP mRNA was also induced by NO donors S-nitroso-N-acetyl-DL-penicillamine (SNAP) or NOC18, or a peroxynitrite generator 3-(4-morpholinyl)-sydnonimine hydrochloride (SIN-1). Bip/GRP78, an ER chaperone which is known to be induced by ER stress, was also induced by SNAP or SIN-1, indicating that NO causes ER stress. These results suggest that NO-induced apoptosis in MG5 cells occurs through the ER stress pathway involving CHOP, but is independent of p53.


Assuntos
Apoptose , Proteínas Estimuladoras de Ligação a CCAAT/metabolismo , Regulação da Expressão Gênica , Proteínas de Choque Térmico , Microglia/metabolismo , Óxido Nítrico/metabolismo , Fatores de Transcrição/metabolismo , Animais , Proteínas Estimuladoras de Ligação a CCAAT/genética , Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Linhagem Celular , Chaperona BiP do Retículo Endoplasmático , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , Camundongos , Microglia/citologia , Microglia/efeitos dos fármacos , Chaperonas Moleculares/genética , Chaperonas Moleculares/metabolismo , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , S-Nitroso-N-Acetilpenicilamina/farmacologia , Fator de Transcrição CHOP , Fatores de Transcrição/genética , Proteína Supressora de Tumor p53/deficiência , Proteína Supressora de Tumor p53/metabolismo
7.
FEBS Lett ; 478(1-2): 141-6, 2000 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-10922486

RESUMO

The gene for a transcription factor hepatocyte nuclear factor-4alpha (HNF-4alpha) is responsible for maturity-onset diabetes of the young, type 1. We examined hormonal regulation of the HNF-4alpha gene in the liver. Stimulation of primary-cultured rat hepatocytes with dexamethasone or glucagon led to induction of HNF-4alpha mRNA, being antagonized by insulin. In the liver of streptozotocin-induced diabetic rat, mRNA and protein levels for HNF-4alpha were elevated, and were normalized by insulin treatment. Therefore, HNF-4alpha in the liver is likely to be involved in the regulation of glucose metabolism in response to these hormones.


Assuntos
Proteínas de Ligação a DNA , Dexametasona/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Glucagon/farmacologia , Insulina/farmacologia , Fígado/efeitos dos fármacos , Fosfoproteínas/genética , Fatores de Transcrição/genética , Animais , Western Blotting , Células Cultivadas , Dexametasona/antagonistas & inibidores , Diabetes Mellitus Experimental/induzido quimicamente , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/metabolismo , Glucagon/antagonistas & inibidores , Glucose/metabolismo , Fator 4 Nuclear de Hepatócito , Antagonistas da Insulina/farmacologia , Fígado/citologia , Fígado/metabolismo , Fígado/patologia , Masculino , Fosfoproteínas/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Fatores de Transcrição/metabolismo , Ativação Transcricional/efeitos dos fármacos
8.
FEBS Lett ; 494(1-2): 105-11, 2001 Apr 06.
Artigo em Inglês | MEDLINE | ID: mdl-11297744

RESUMO

Transcription of genes for enzymes of the ornithine cycle is activated by hormones such as glucocorticoids and glucagon. Promoters and enhancers of several genes for the enzymes interact with the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors, and C/EBPbeta has been suggested to mediate glucocorticoid response of the gene for arginase, the last enzyme of the cycle. To determine the contribution of C/EBPbeta to hormonal regulation of genes for ornithine cycle enzymes, we examined mice with targeted disruption of the C/EBPbeta gene. Induction of genes for the enzymes by intraperitoneal injection of dexamethasone and glucagon was almost intact in the liver of C/EBPbeta-deficient mice. On the other hand, in primary-cultured hepatocytes derived from C/EBPbeta-deficient mice, induction of genes for the first enzyme carbamylphosphate synthetase, as well as for arginase, in response to dexamethasone and/or glucagon was severely impaired. Therefore, C/EBPbeta is required for hormonal induction of the genes for ornithine cycle enzymes in primary-cultured hepatocytes, while the deficiency of C/EBPbeta is compensated for in vivo.


Assuntos
Arginase/genética , Proteína beta Intensificadora de Ligação a CCAAT/metabolismo , Dexametasona/metabolismo , Glucagon/metabolismo , Glucocorticoides/metabolismo , Zíper de Leucina , Ornitina Carbamoiltransferase/genética , Fatores de Transcrição/metabolismo , Ativação Transcricional , Animais , Argininossuccinato Liase/genética , Argininossuccinato Sintase/genética , Proteína beta Intensificadora de Ligação a CCAAT/genética , Células Cultivadas , Dexametasona/farmacologia , Glucagon/farmacologia , Glucocorticoides/farmacologia , Hepatócitos/citologia , Hepatócitos/metabolismo , Camundongos , Camundongos Knockout , Ornitina/metabolismo , Fatores de Transcrição/genética
9.
Brain Res Mol Brain Res ; 83(1-2): 1-8, 2000 Nov 10.
Artigo em Inglês | MEDLINE | ID: mdl-11072090

RESUMO

Nitric oxide (NO) is involved in many physiological and pathological processes in the brain. NO is synthesized from arginine by nitric oxide synthase (NOS), and the citrulline generated as a by-product can be recycled to arginine by argininosuccinate synthetase (AS) and argininosuccinate lyase (AL) via the citrulline-NO cycle. When neuronal PC12 cells differentiated with nerve growth factor were treated with interferon-gamma (IFNgamma) and tumor necrosis factor-alpha (TNFalpha), iNOS and AS mRNAs and proteins were markedly induced, with AL mRNA and protein being weakly induced. Cationic amino acid transporter-1 and -2 were not induced. IFNgamma or TNFalpha alone was ineffective. A large amount of NO (190 microM NO(2)(-) plus NO(3)(-) in culture medium in 24 h) was produced from arginine by cytokine-stimulated cells, and arginine could be replaced by citrulline. iNOS induction and NO production were attenuated by dexamethasone and dibutyryl cAMP and even more strongly so when combined. Therefore, a large amount of NO is produced in cytokine-stimulated PC12 cells following to induction of iNOS and citrulline-arginine recycling is important for NO production.


Assuntos
Arginina/metabolismo , Neurônios/enzimologia , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico/metabolismo , Fator de Necrose Tumoral alfa/farmacologia , Animais , Antineoplásicos/farmacologia , Argininossuccinato Liase/metabolismo , Argininossuccinato Sintase/metabolismo , Bucladesina/farmacologia , Citrulina/metabolismo , Dexametasona/farmacologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Glucocorticoides/farmacologia , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , Fator de Crescimento Neural/farmacologia , Neurônios/citologia , Neurônios/efeitos dos fármacos , Óxido Nítrico Sintase Tipo II , Células PC12 , RNA Mensageiro/análise , Ratos
10.
Brain Res Mol Brain Res ; 90(2): 165-73, 2001 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-11406294

RESUMO

Nitric oxide (NO) produced by activated microglia has been implicated in many pathophysiological events in the brain including neurodegenerative diseases. Cellular NO production depends absolutely on the availability of arginine, a substrate of NO synthase (NOS). Murine microglial MG5 cells were treated with bacterial lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma), and expression of inducible NO synthase (iNOS) and arginine-supplying enzymes was investigated by RNA blot analysis. iNOS mRNA was strongly induced after treatment and reached a maximum at 6-12 h. mRNA for argininosuccinate synthetase (AS), a citrulline-arginine recycling enzyme, increased at 6 h and reached a maximum at 12 h. Immunoblot analysis showed that iNOS and AS proteins were also induced. In addition, mRNA encoding the cationic amino acid transporter-2 (CAT-2) was strongly induced shortly after treatment. Induction of mRNAs for iNOS, AS, and CAT-2 by LPS/IFN-gamma was also observed following stimulation of rat primary microglial cells. These results strongly suggest that both arginine transport by CAT-2 and citrulline-arginine recycling are important for high-output production of NO in activated microglial cells.


Assuntos
Argininossuccinato Sintase/genética , Proteínas de Transporte/genética , Regulação Enzimológica da Expressão Gênica/fisiologia , Proteínas de Membrana/genética , Microglia/enzimologia , Óxido Nítrico Sintase/genética , Sistemas de Transporte de Aminoácidos Básicos , Animais , Antineoplásicos/farmacologia , Argininossuccinato Sintase/metabolismo , Proteínas de Transporte/metabolismo , Células Cultivadas , Citrulina/metabolismo , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Interferon gama/farmacologia , Cinética , Lipopolissacarídeos/farmacologia , Proteínas de Membrana/metabolismo , Camundongos , Camundongos Knockout , Microglia/citologia , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , RNA Mensageiro/análise , Ratos , Ratos Wistar
11.
Neurosci Lett ; 310(2-3): 89-92, 2001 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-11585574

RESUMO

We investigated the effect of nitric oxide (NO) on the proliferation of microglial MG5 cells established from p53-deficient mice. Cells were treated with bacterial lipopolysaccharide and interferon-gamma, and expression of inducible NO synthase (iNOS) and p21/waf1, a cyclin-dependent kinase inhibitor protein which is a critical downstream effector of p53, was investigated by RNA blot and immunoblot analyses. iNOS mRNA was induced 2 h after treatment and increased with time up to 24 h. p21 mRNA was expressed at a low level in untreated cells and increased with a kinetics similar to that for iNOS mRNA. iNOS and p21 proteins were also induced. An NO donor SNAP induced p21 mRNA and protein. SNAP inhibited incorporation of [(3)H]thymidine in MG5 cells in a dose-dependent manner. 8-Bromo-cGMP neither induced p21 mRNA nor inhibited [(3)H]thymidine incorporation. These results suggest that NO inhibits the proliferation of MG5 cells by induction of p21, which occurs independent of p53 and cGMP.


Assuntos
GMP Cíclico/análogos & derivados , GMP Cíclico/metabolismo , Ciclinas/metabolismo , Microglia/citologia , Óxido Nítrico/metabolismo , Penicilamina/análogos & derivados , Proteína Supressora de Tumor p53/genética , Animais , Antineoplásicos/farmacologia , Divisão Celular/fisiologia , Células Cultivadas , GMP Cíclico/farmacologia , Inibidor de Quinase Dependente de Ciclina p21 , Ciclinas/genética , Expressão Gênica/efeitos dos fármacos , Expressão Gênica/fisiologia , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , Camundongos , Camundongos Mutantes , Doadores de Óxido Nítrico/farmacologia , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II , Penicilamina/farmacologia , RNA Mensageiro/análise , Proteína Supressora de Tumor p53/metabolismo
12.
Nitric Oxide ; 5(3): 252-60, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11384198

RESUMO

Decreased availability of arginine and impaired production of NO (nitric oxide) have been implicated in the development of endothelial dysfunction. Citrulline formed by the NOS reaction is recycled to arginine by the citrulline-NO cycle, which is composed of NOS, argininosuccinate synthetase (AS), and argininosuccinate lyase. Therefore, we investigated the alterations of these enzymes in the aorta of streptozotocin (STZ)-induced diabetic rats. eNOS and AS mRNAs were increased by three- to fourfold 1-2 weeks after STZ treatment and decreased at 4 weeks. AL mRNA was weakly induced. Induction of eNOS and AS proteins was also observed. Cationic amino acid transporter (CAT)-1 mRNA remained little changed, and CAT-2 mRNA was not detected. The plasma nitrogen oxide levels were increased 1-2 weeks after STZ treatment and decreased at 4 weeks. Transforming growth factor-beta1 (TGF-beta1) mRNA in the aorta was also induced. TGF-beta1 induced eNOS and AS mRNAs in human umbilical vein endothelial cells but inhibited the proliferation of HUVEC. These results indicate that eNOS and AS are coinduced in the aorta in early stages of STZ-induced diabetic rats and that the induction is mediated by TGF-beta1. The results also suggest that TGF-beta1 works antiatherogenically at early stages of diabetes by increasing NO production, whereas prolonged elevation of TGF-beta1 functions atherogenically by inhibiting endothelial cell growth.


Assuntos
Aorta/enzimologia , Arginina/metabolismo , Diabetes Mellitus Experimental/enzimologia , Endotélio Vascular/enzimologia , Óxido Nítrico Sintase/genética , Sistemas de Transporte de Aminoácidos Básicos , Animais , Argininossuccinato Liase/genética , Argininossuccinato Sintase/genética , Glicemia/metabolismo , Proteínas de Transporte/genética , Divisão Celular/efeitos dos fármacos , Diabetes Mellitus Experimental/fisiopatologia , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/fisiologia , Indução Enzimática , Regulação Enzimológica da Expressão Gênica/fisiologia , Humanos , Insulina/sangue , Fígado/enzimologia , Masculino , Proteínas de Membrana/genética , Óxido Nítrico Sintase/biossíntese , Óxido Nítrico Sintase Tipo III , RNA Mensageiro/genética , Ratos , Ratos Wistar , Transcrição Gênica , Fator de Crescimento Transformador beta/genética , Fator de Crescimento Transformador beta/farmacologia , Veias Umbilicais
13.
Proc Natl Acad Sci U S A ; 98(19): 10845-50, 2001 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-11526215

RESUMO

Excessive nitric oxide (NO) production in cytokine-activated beta cells has been implicated in beta cell disruption in type 1 diabetes. beta cells are very vulnerable to NO-induced apoptosis. However, the mechanism underlying this phenomenon is unclear. Low concentrations of NO that lead to apoptosis apparently do not cause severe DNA damage in mouse MIN6 beta cells. CHOP, a C/EBP homologous protein that is induced by endoplasmic reticulum (ER) stress and plays a role in growth arrest and cell death, was induced by a NO donor, S-nitroso-N-acetyl-D,L-penicillamine (SNAP). SNAP increased cytosolic Ca(2+), and only agents depleting ER Ca(2+) induced CHOP expression and led to apoptosis, suggesting that NO depletes ER Ca(2+). Overexpression of calreticulin increased the Ca(2+) content of ER and afforded protection to cells against NO-mediated apoptosis. Furthermore, pancreatic islets from CHOP knockout mice showed resistance to NO. We conclude that NO depletes ER Ca(2+), causes ER stress, and leads to apoptosis. Thus, ER Ca(2+) stores are a new target of NO, and the ER stress pathway is a major mechanism of NO-mediated beta cell apoptosis.


Assuntos
Apoptose , Retículo Endoplasmático/metabolismo , Ilhotas Pancreáticas/citologia , Óxido Nítrico/metabolismo , Animais , Proteínas Estimuladoras de Ligação a CCAAT/genética , Cálcio/metabolismo , Proteínas de Ligação ao Cálcio/genética , Calreticulina , GMP Cíclico/metabolismo , Dano ao DNA , Resistência a Medicamentos , Retículo Endoplasmático/efeitos dos fármacos , Homeostase , Interferon gama/farmacologia , Interleucina-1/farmacologia , Ilhotas Pancreáticas/efeitos dos fármacos , Ilhotas Pancreáticas/metabolismo , Camundongos , Doadores de Óxido Nítrico/farmacologia , Penicilamina/análogos & derivados , Penicilamina/farmacologia , Ribonucleoproteínas/genética , Fator de Transcrição CHOP , Fatores de Transcrição/genética , Células Tumorais Cultivadas , Fator de Necrose Tumoral alfa/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA